Patents by Inventor Ye-song Gu

Ye-song Gu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide, antibody thereof, and method of assessing risk of oral cancer by using peptide
    Patent number: 10379123
    Abstract: The present application discloses a THLW peptide, an amino acid sequence of which is represented by SEQ ID No. 1. The THLW peptide can be used as a biomarker for diseases, such as oral cancer and cervical cancer, etc., relating to infection of human papilloma virus (HPV), therefore, THLW peptide as an antigen or an anti-THLW peptide antibody prepared can be used to detect the risk of developing cancer for sample providers.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: August 13, 2019
    Assignees: TUNGCHAI UNIVERSITY, TAICHUNG VETERANS GENERAL HOSPITAL
    Inventors: Feng-Di Lung, Ye-song Gu, Bor-rung Ou, Chi-Sheng Cheng, Man-Yee Chan
  • NOVEL PEPTIDE, ANTIBODY THEREOF, AND METHOD OF ASSESSING RISK OF ORAL CANCER BY USING PEPTIDE
    Publication number: 20180113132
    Abstract: The present application discloses a THLW peptide, an amino acid sequence of which is represented by SEQ ID No. 1. The THLW peptide can be used as a biomarker for diseases, such as oral cancer and cervical cancer, etc., relating to infection of human papilloma virus (HPV), therefore, THLW peptide as an antigen or an anti-THLW peptide antibody prepared can be used to detect the risk of developing cancer for sample providers.
    Type: Application
    Filed: October 25, 2017
    Publication date: April 26, 2018
    Inventors: Feng-Di Lung, Ye-song Gu, Bor-rung Ou, Chi-Sheng Cheng, Man-Yee Chan